G
GreenBone
Biotech & Life Sciences · Faenza, Italy · Founded 2015
GreenBone Ortho aims to be a leading bone regenerative company that provides innovative, cost-effective, and easy-to-use solutions inspired by nature to cure severe orthopedic and bone diseases MoreLess
Developer of biomimetic bone implants designed to treat severe fractures and conditions such as trauma and tumors that result in extensive bone loss. The company's implants transform bamboo wood into an established, widely used biomaterial called hydroxyapatite to serve as a bone graft scaffold that features weight-bearing and bone regeneration properties needed for large implants, enabling patients to get to use bio-inspired methods that will help cure severe diseases. Keywords: Pharmaceuticals and Biotechnology, Biomimetic Bone, Biomimetic Bone Implants, Bone Graft, Bone Graft Scaffold, Bone Implants, Bone Regeneration.
Company overview
GreenBone company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2015
- Headquarters
- Faenza, Italy
- Employees
- 23
- Open positions
- None listed
- Dealroom signal
- 64.8
Valuation & funding
GreenBone funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GRANT✓Other financing | Oct 2021 | $2.5M | — | European Innovation Council | — |
| SERIES B✓Equity / VC | Apr 2021 | $11M | $44M | CDP Venture Capital · 3B Future Health Fund · META · Innogest Capital | — |
| SERIES A✓Equity / VC | Jun 2017 | $9.2M | $37M | CDP Venture Capital · Italian Angels for Growth · Innogest Capital · 3B Future Health Fund | — |
| SEED✓Equity / VC | Sep 2015 | $3.3M | $13M | META · Italian Angels for Growth | — |
| SPINOUT✓Other financing | Jan 2015 | $0 | — | National Research Council of Italy | — |
Financials
Revenue, earnings and profit over time
Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.
Growth signals
GreenBone website traffic
Latest recorded traffic for GreenBone is 550 monthly website visits, down 40.9% over the last three months. GreenBone's team declined 14.8% over the past year.
Comparisons
GreenBone compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
GreenBone's talent
Source: Dealroom Talent Intelligence.
Investors
7 investors on GreenBone's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where GreenBone has talent and traffic
team presence
In the news
Latest news about GreenBone
Recent press, funding announcements, and product moves mentioning GreenBone — open to read from the original sources.
Market sentiment
What the market is saying about GreenBone
An AI-synthesized read of the highest-engagement posts about GreenBone on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See GreenBone’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.